Lyleq Tablet
Product Images NDC 50102-300

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lyleq (NDC 50102-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Mean ± Sd Norethindrone Plasma Concentrations Following Norethindrone Administration (Norethindrone Fig1)

A pharmacokinetic curve showing plasma concentration (Cp mg/mL) over time (hours) for oral norethindrone 0.35 mg tablets. The graph depicts a rapid decrease in drug concentration from a peak near time zero to near zero by 48 hours, with error bars indicating variability at each time point.*

FDA Label Image

Blister Pack (Norethindrone Fig2)

An instructional diagram showing the placement of a day label strip on a medication blister card. The image includes a hand positioning a label strip with days of the week to be placed on the blister where the corresponding medicine tablets are located, helping users to track daily doses.*

FDA Label Image

Package Label-principal Display Panel (0.35 mg 1 Blister Pack 28 Tablets)

Packaging label for Lyleq 0.35 mg tablets containing Norethindrone. The label displays the product name, strength, and dosage form as oral tablets in a blister pack of 28 tablets. Manufactured for Afaxys Pharma, LLC, Charleston, SC, USA, and produced by Aurobindo Pharma Limited in India. The label includes the NDC code 50102-300-11 and a warning that the product does not protect against HIV or other sexually transmitted diseases.*

FDA Label Image

Package Label-principal Display Panel (0.35 mg 3 Blister Carton 28 Tablets)

Packaging label for Lyleq (Norethindrone Tablets USP) 0.35 mg oral tablets by Afaxys Pharma, LLC. The label states the product contains 3 blister packs with 28 tablets each. Manufacturing information includes Aurobindo Pharma Limited in India and product origin as the Netherlands. Additional labeling includes storage instructions and dispensing notes.*

FDA Label Image

Chemical Structure (Norethindrone Str)

Chemical structure of norethindrone, the active ingredient in Lyleq oral tablets, shown with a labeled molecular diagram and noted as belonging to the therapeutic class oral contraceptive.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.